BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31555829)

  • 1. Risk Factors for Kaposi's Sarcoma-Associated Herpesvirus DNA in Blood and in Saliva in Rural Uganda.
    Nalwoga A; Nakibuule M; Marshall V; Miley W; Labo N; Cose S; Whitby D; Newton R
    Clin Infect Dis; 2020 Aug; 71(4):1055-1062. PubMed ID: 31555829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutual detection of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in blood and saliva of Cameroonians with and without Kaposi's sarcoma.
    Labo N; Marshall V; Miley W; Davis E; McCann B; Stolka KB; Ndom P; Hemingway-Foday JJ; Abassora M; Newton R; Smith JS; Whitby D
    Int J Cancer; 2019 Nov; 145(9):2468-2477. PubMed ID: 31265124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrafamiliar transmission of Kaposi's sarcoma-associated herpesvirus and seronegative infection in family members of classic Kaposi's sarcoma patients.
    Mancuso R; Brambilla L; Agostini S; Biffi R; Hernis A; Guerini FR; Agliardi C; Tourlaki A; Bellinvia M; Clerici M
    J Gen Virol; 2011 Apr; 92(Pt 4):744-51. PubMed ID: 21216985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma.
    Vieira J; Huang ML; Koelle DM; Corey L
    J Virol; 1997 Sep; 71(9):7083-7. PubMed ID: 9261440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental determinants of Kaposi's sarcoma-associated herpesvirus (KSHV) transmission in rural Uganda (ENDKU study): Contributions to research on KSHV infection and reactivation in African children; A longitudinal cohort study.
    Sabourin KR; Nalwoga A; Whitby D; Newton R; Rochford R
    Cancer Epidemiol; 2022 Jun; 78():102154. PubMed ID: 35381467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates.
    Koelle DM; Huang ML; Chandran B; Vieira J; Piepkorn M; Corey L
    J Infect Dis; 1997 Jul; 176(1):94-102. PubMed ID: 9207354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for Kaposi's sarcoma: a case-control study of HIV-seronegative people in Uganda.
    Ziegler J; Newton R; Bourboulia D; Casabonne D; Beral V; Mbidde E; Carpenter L; Reeves G; Parkin DM; Wabinga H; Mbulaiteye S; Jaffe H; Weiss R; Boshoff C;
    Int J Cancer; 2003 Jan; 103(2):233-40. PubMed ID: 12455038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of Gammaherpesvirus Shedding in Saliva Among Ugandan Children and Their Mothers.
    Newton R; Labo N; Wakeham K; Marshall V; Roshan R; Nalwoga A; Sebina I; Muhangi L; Webb EL; Miley W; Rochford R; Elliott AM; Whitby D
    J Infect Dis; 2018 Aug; 218(6):892-900. PubMed ID: 29762709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirtuin 6 Attenuates Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Suppressing Ori-Lyt Activity and Expression of RTA.
    Hu M; Armstrong N; Seto E; Li W; Zhu F; Wang PC; Tang Q
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
    Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
    AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel.
    Davidovici B; Karakis I; Bourboulia D; Ariad S; Zong J; Benharroch D; Dupin N; Weiss R; Hayward G; Sarov B; Boshoff C
    J Natl Cancer Inst; 2001 Feb; 93(3):194-202. PubMed ID: 11158187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda.
    Newton R; Ziegler J; Bourboulia D; Casabonne D; Beral V; Mbidde E; Carpenter L; Parkin DM; Wabinga H; Mbulaiteye S; Jaffe H; Weiss R; Boshoff C
    Br J Cancer; 2003 Aug; 89(3):502-4. PubMed ID: 12888820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypic and clinicopathological characterization of Kaposi's sarcoma-associated herpesvirus infection in Japan.
    Kanno T; Sato Y; Nakamura T; Sakamoto K; Sata T; Katano H
    J Med Virol; 2010 Mar; 82(3):400-6. PubMed ID: 20087946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Immunodeficiency Virus-Associated Exosomes Promote Kaposi's Sarcoma-Associated Herpesvirus Infection via the Epidermal Growth Factor Receptor.
    Chen L; Feng Z; Yuan G; Emerson CC; Stewart PL; Ye F; Jin G
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32051269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal analysis of the humoral response to Kaposi's sarcoma-associated herpesvirus after primary infection in children.
    Olp LN; Minhas V; Gondwe C; Poppe LK; Rogers AM; Kankasa C; West JT; Wood C
    J Med Virol; 2016 Nov; 88(11):1973-81. PubMed ID: 27062052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium falciparum Malaria Is Associated With Increased Kaposi Sarcoma-Associated Herpesvirus (KSHV) Seropositivity and Higher KSHV Antibody Breadth and Magnitude: Results of a Case-Control Study From Rural Uganda.
    Nalwoga A; Sabourin KR; Miley W; Jackson C; Maktabi M; Labo N; Mugisha J; Whitby D; Rochford R; Newton R
    J Infect Dis; 2024 Feb; 229(2):432-442. PubMed ID: 37536670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda.
    Newton R; Ziegler J; Bourboulia D; Casabonne D; Beral V; Mbidde E; Carpenter L; Reeves G; Parkin DM; Wabinga H; Mbulaiteye S; Jaffe H; Weiss R; Boshoff C;
    Int J Cancer; 2003 Jan; 103(2):226-32. PubMed ID: 12455037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents.
    Mayama S; Cuevas LE; Sheldon J; Omar OH; Smith DH; Okong P; Silvel B; Hart CA; Schulz TF
    Int J Cancer; 1998 Sep; 77(6):817-20. PubMed ID: 9714046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma-associated herpesvirus-like DNA sequences (KSHV/HHV-8) in oral AIDS-Kaposi's sarcoma: a PCR and clinicopathologic study.
    Flaitz CM; Jin YT; Hicks MJ; Nichols CM; Wang YW; Su IJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Feb; 83(2):259-64. PubMed ID: 9117759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group.
    Chang Y; Ziegler J; Wabinga H; Katangole-Mbidde E; Boshoff C; Schulz T; Whitby D; Maddalena D; Jaffe HW; Weiss RA; Moore PS
    Arch Intern Med; 1996 Jan; 156(2):202-4. PubMed ID: 8546554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.